273 related articles for article (PubMed ID: 33509919)
1. Determining the Degree of Dopaminergic Denervation Based on the Loss of Nigral Hyperintensity on SMWI in Parkinsonism.
Bae YJ; Song YS; Kim JM; Choi BS; Nam Y; Choi JH; Lee WW; Kim JH
AJNR Am J Neuroradiol; 2021 Apr; 42(4):681-687. PubMed ID: 33509919
[TBL] [Abstract][Full Text] [Related]
2. Comparison of susceptibility-weighted imaging and susceptibility map-weighted imaging for the diagnosis of Parkinsonism with nigral hyperintensity.
Bae YJ; Song YS; Choi BS; Kim JM; Nam Y; Kim JH
Eur J Radiol; 2021 Jan; 134():109398. PubMed ID: 33264728
[TBL] [Abstract][Full Text] [Related]
3. Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake.
Bae YJ; Choi BS; Kim JM; Ai WA; Yun I; Song YS; Nam Y; Cho SJ; Kim JH
Neuroradiology; 2023 Jul; 65(7):1101-1109. PubMed ID: 37209181
[TBL] [Abstract][Full Text] [Related]
4. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.
Bae YJ; Kim JM; Kim E; Lee KM; Kang SY; Park HS; Kim KJ; Kim YE; Oh ES; Yun JY; Kim JS; Jeong HJ; Jeon B; Kim SE
Mov Disord; 2016 May; 31(5):684-92. PubMed ID: 26990970
[TBL] [Abstract][Full Text] [Related]
5. Initial diagnostic workup of parkinsonism: Dopamine transporter positron emission tomography versus susceptibility map-weighted imaging at 3T.
Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Hwang KH; Lee H; Kim EY
Parkinsonism Relat Disord; 2019 May; 62():171-178. PubMed ID: 30580909
[TBL] [Abstract][Full Text] [Related]
6. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
7. A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism.
Sung YH; Kim JS; Yoo SW; Shin NY; Nam Y; Ahn TB; Yoo D; Lee KM; Kim HG; Koh SB; Kim J; Kim I; Kwon DY; Lee Y; Kim C; Chung SJ; Jo S; Lee SH; Kim SJ; Kim M; Lyoo CH; Baek MS; Kang SY; Chang SK; Jo SW; Lee SA; Ma HI; Kim YE; Kim ES; Kim YJ; Kim HS; Woo MH; Choi HJ; Kim EY
Eur Radiol; 2022 May; 32(5):3597-3608. PubMed ID: 35064313
[TBL] [Abstract][Full Text] [Related]
8. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
[TBL] [Abstract][Full Text] [Related]
9. Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease.
Kim HK; Kim T; Baek MS; Kim EY; Sung YH; Lee JH; Ryu YH; Ahn SJ; Yoo HS; Lyoo CH
Eur J Neurol; 2023 Jun; 30(6):1639-1647. PubMed ID: 36915220
[TBL] [Abstract][Full Text] [Related]
10. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
11. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
12. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
[TBL] [Abstract][Full Text] [Related]
13. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
Booij J; Speelman JD; Horstink MW; Wolters EC
Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
[TBL] [Abstract][Full Text] [Related]
14. Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with
Bae YJ; Kim JM; Kim KJ; Kim E; Park HS; Kang SY; Yoon IY; Lee JY; Jeon B; Kim SE
Radiology; 2018 Apr; 287(1):285-293. PubMed ID: 29232183
[TBL] [Abstract][Full Text] [Related]
15. Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.
Kahraman D; Eggers C; Schicha H; Timmermann L; Schmidt M
J Neurol; 2012 Feb; 259(2):251-60. PubMed ID: 21750954
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic denervation is not necessary to induce gait disorders in atypical parkinsonian syndrome.
Allali G; Garibotto V; Mainta IC; Armand S; Camicioli R; Ratib O; Zaidi H; Herrmann FR; Assal F
J Neurol Sci; 2015 Apr; 351(1-2):127-132. PubMed ID: 25772188
[TBL] [Abstract][Full Text] [Related]
17. Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease.
Alvarez-Fischer D; Blessmann G; Trosowski C; Béhé M; Schurrat T; Hartmann A; Behr TM; Oertel WH; Höglinger GU; Höffken H
Neuroimage; 2007 Oct; 38(1):5-12. PubMed ID: 17716921
[TBL] [Abstract][Full Text] [Related]
18. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
19. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C).
Muñoz E; Iranzo A; Rauek S; Lomeña F; Gallego J; Ros D; Santamaría J; Tolosa E
J Neurol; 2011 Dec; 258(12):2248-53. PubMed ID: 21633903
[TBL] [Abstract][Full Text] [Related]
20. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
